• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Role of Mitochondrial Enzymes in Gastrointestinal system of Mitochondrial Myopathy patients

Role of Mitochondrial Enzymes in Gastrointestinal system of Mitochondrial Myopathy patients

Muhammad Nadeem1, Julian Ambrus, MD1, Steven Schwaitzberg, MD1, John Butsch, MD2. 1University at Buffalo, 2Buffalo General Medical Center

Introduction: Mitochondria is a small energy producing structure of a cell. Mitochondrial myopathy (MM) is mixed disorder clinically, which can affect various systems besides skeletal muscle. MM starts with muscle weakness or exercise weakness. MM patients have decreased skeletal muscle mitochondrial function than the healthy person, because of weakened intrinsic mitochondrial function and decreased mitochondrial volume density. No one has studied the MM role in GERD and constipation so far. This study is aimed to see effects of MM on the gastrointestinal system specifically gastroesophageal reflux disease (GERD), gall bladder issues, and constipation.

Methods: Between May 2011 and June 2016, 101 MM diagnosed  patients at Buffalo General Hospital were included in this retrospective study. We assessed their DeMeester score for GERD and Wexner’s constipation questionnaire for constipation. DeMeester Score >14 and constipation score >15 were set points for GERD and constipation respectively. Data was analyzed by using SPSS version 24. Mitochondrial enzymes were assessed by using their muscle biopsy report.

Results: Out of 101 (85.1% female, 14.9% male) mitochondrial myopathy patients, 38.6% and 13.9% were suffering from GERD and constipation respectively.  35.1%, 43.4% and 95.9% patients had gall bladder issues, obstructive sleep apnea (OSA) and fatigue respectively. MM GERD patients  (87.2% female, 12.8 male) had mean DeMeester score  22.56 (SD: 6.49) more than normal although 76.3% patients were on GERD medications and 29.2 % patients had NADH cytochrome C reductase, cytochrome C oxidase and citrate synthase abnormal mitochondrial enzyme in MM associated GERD but 26.1% MM patients had abnormal cytochrome C oxidase enzyme only. MM along with constipation had mean wexner’s constipation score 19.14 (SD: 2.568) more than the normal although 94.9% were taking enema, medications or digital assistance. 50 % patients had cytochrome C oxidase and NADH cytochrome C reductase enzymes were abnormal in those patients. 29.4% MM associated gall bladder issues patients had cytochrome C oxidase abnormal. 63.6% MM associated GERD and constipation patients had gall bladder issues.

Conclusion: In this present study, we found that MM had effects on gastrointestinal system causing GERD, constipation and gall bladder issues. GERD, constipation and gall bladder problems are common in MM patients even patients are taking medications for GERD and constipation. Cytochrome C oxidase, citrate synthase and NADH cytochrome C reductase are the most commonly impaired mitochondrial enzyme in MM patients and MM associated GERD, constipation and gall bladder issues patients.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 88550

Program Number: P076

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

44

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals